company background image
HOOK

HOOKIPA Pharma NasdaqGS:HOOK Stock Report

Last Price

US$0.98

Market Cap

US$53.6m

7D

-4.8%

1Y

-66.4%

Updated

04 Dec, 2022

Data

Company Financials +
HOOK fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

HOOK Stock Overview

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform.

HOOKIPA Pharma Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for HOOKIPA Pharma
Historical stock prices
Current Share PriceUS$0.98
52 Week HighUS$3.25
52 Week LowUS$0.97
Beta0.73
1 Month Change-22.21%
3 Month Change-29.99%
1 Year Change-66.44%
3 Year Change-88.06%
5 Year Changen/a
Change since IPO-93.00%

Recent News & Updates

Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Nov 19
Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Recent updates

Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Nov 19
Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues

Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

May 18
Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts

Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

Oct 01
Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

Apr 19
Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?

If You Had Bought HOOKIPA Pharma (NASDAQ:HOOK) Shares A Year Ago You'd Have Earned 64% Returns

Mar 15
If You Had Bought HOOKIPA Pharma (NASDAQ:HOOK) Shares A Year Ago You'd Have Earned 64% Returns

What Kind Of Shareholders Hold The Majority In HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Shares?

Jan 22
What Kind Of Shareholders Hold The Majority In HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Shares?

Introducing HOOKIPA Pharma (NASDAQ:HOOK), A Stock That Climbed 55% In The Last Year

Dec 11
Introducing HOOKIPA Pharma (NASDAQ:HOOK), A Stock That Climbed 55% In The Last Year

Shareholder Returns

HOOKUS BiotechsUS Market
7D-4.8%4.2%1.5%
1Y-66.4%-7.4%-14.9%

Return vs Industry: HOOK underperformed the US Biotechs industry which returned -7.4% over the past year.

Return vs Market: HOOK underperformed the US Market which returned -14.9% over the past year.

Price Volatility

Is HOOK's price volatile compared to industry and market?
HOOK volatility
HOOK Average Weekly Movement8.2%
Biotechs Industry Average Movement11.2%
Market Average Movement7.4%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.3%

Stable Share Price: HOOK is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: HOOK's weekly volatility has decreased from 14% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011144Joern Aldaghttps://www.hookipapharma.com

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company’s lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers.

HOOKIPA Pharma Inc. Fundamentals Summary

How do HOOKIPA Pharma's earnings and revenue compare to its market cap?
HOOK fundamental statistics
Market CapUS$53.63m
Earnings (TTM)-US$73.84m
Revenue (TTM)US$10.32m

5.2x

P/S Ratio

-0.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HOOK income statement (TTM)
RevenueUS$10.32m
Cost of RevenueUS$73.47m
Gross Profit-US$63.16m
Other ExpensesUS$10.68m
Earnings-US$73.84m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.35
Gross Margin-612.21%
Net Profit Margin-715.77%
Debt/Equity Ratio1.9%

How did HOOK perform over the long term?

See historical performance and comparison